Elon Musk's Peptide Success Story: Wegovy, Mounjaro, and the Tweet That Made GLP-1s Mainstream
Elon Musk helped push GLP-1 weight-loss drugs into the public conversation after crediting fasting, Wegovy, and later Mounjaro for a leaner look.
Peptides
Peer-reviewed research on therapeutic peptides — what the studies actually show and what they do not.
Serena Williams' Peptide Pivot: GLP-1s, Motherhood, and Metabolic Reality
Serena Williams went public about using Zepbound (tirzepatide) after struggling with post-pregnancy weight changes. What her story teaches about GLP-1s, postpartum biology, and why discipline alone isn't always the answer.
Shaq's Peptide Wake-Up Call: GLP-1s, Sleep, and Longevity
Shaquille O'Neal went public about using Zepbound (tirzepatide) for obstructive sleep apnea. What his story teaches about GLP-1s, sleep, and longevity.
GLP-1 Peptides Explained: What the Weight-Loss Conversation Actually Changed
GLP-1 receptor agonists shifted how clinicians and the public think about obesity in just a few years. Here's what they actually are, what the research shows, and what's still being studied.
BPC-157 and Tendon Healing: What the 2026 Literature Review Actually Says
A new systematic review pulls every published BPC-157 tendon study to date. The animal data are striking; the human data remain almost nonexistent.